中国药品价格信息共享机制研究—基于政务信息共享理论的视角

doi:10.5246/jcps.2018.08.059

中国药学(英文版) ›› 2018, Vol. 27 ›› Issue (8): 582-587.DOI: 10.5246/jcps.2018.08.059

• 【药事管理与临床药学专栏】 • 上一篇下一篇

中国药品价格信息共享机制研究—基于政务信息共享理论的视角

王帅¹, 尹婷¹, 罗宁泰¹, 刘小平², 江滨^1*

1. 北京大学医学部药学院药事管理与临床药学系, 北京 100191
2. 中国药品监督管理研究会, 北京 100050

收稿日期:2018-05-28 修回日期:2018-06-29 出版日期:2018-09-04 发布日期:2018-07-13
通讯作者: Tel.: +86-13601100121, E-mail: binjiang@bjmu.edu.cn
基金资助:
China Society for Drug Regulation (Grant No. 20170518).

Research on the sharing mechanism of drug price information in China- from the perspective of intergovernmental information sharing

Shuai Wang¹, Ting Yin¹, Ningtai Luo¹, Xiaoping Liu², Bin Jiang^1*

1. Department of Administrative and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China
2. China Society for Drug Regulation, Beijing 100050, China

Received:2018-05-28 Revised:2018-06-29 Online:2018-09-04 Published:2018-07-13
Contact: Tel.: +86-13601100121, E-mail: binjiang@bjmu.edu.cn
Supported by:
China Society for Drug Regulation (Grant No. 20170518).

摘要/Abstract

摘要：

建立价格信息共享机制,建设统一的跨部门价格信息平台,是中国政府取消药品价格管制后的新国策。本文以政务信息共享理论为基础,通过文献阅读、专家访谈,提出了中国药品价格信息共享机制,包括制度保障机制、部门协同机制和技术支撑机制。

关键词: 药品价格, 信息共享机制, 跨部门价格信息平台, 政务信息共享

Abstract:

Establishment of sharing mechanism for drug price information to guarantee the construction of a unified cross-departmental price information platform is a new national policy after Chinese government abandoned drug price control. Based on the theory of intergovernmental information sharing, this study aimed to investigate the drug price information sharing mechanism in China through literature research and stakeholder interviews, which included institution guarantee mechanism, department coordination mechanism and technical support mechanism.

Key words: Drug price, Information sharing mechanism, Cross-departmental price information platform, Intergovernmental information sharing

中图分类号:

R951

Supporting:

王帅, 尹婷, 罗宁泰, 刘小平, 江滨. 中国药品价格信息共享机制研究—基于政务信息共享理论的视角[J]. 中国药学(英文版), 2018, 27(8): 582-587.

Shuai Wang, Ting Yin, Ningtai Luo, Xiaoping Liu, Bin Jiang. Research on the sharing mechanism of drug price information in China- from the perspective of intergovernmental information sharing[J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(8): 582-587.

参考文献

[1] Chen, C.; Li, B.; Yang, D.S.; Jiang, B. Implementation of NFS (2012) in Qingdao: from the perspective of public policy implementation. Chin. Pharm. Sci. 2016, 25, 779−784.

[2] Yu, J.X.; Que, M.Y.; Wang, S.; Yin, T.; Wang, J.; Yang, S.; Jiang, B. Framework and local experience of pharmaceutical reimbursement criteria policy (PRCP) in China. Chin. Pharm. Sci. 2017, 26, 390–394

[3] Chen, L.J.; liu, G.Z.; Huang, G.; Yang, D.h.; Jiang, B. Institutional changes of China’s drug regulation and improvement solutions. Chin. Pharm. Sci. 2015, 24, 821–825

[4] Dawes, S.S. Interagency information sharing: Expected benefits, manageable risks. J. Policy. Anal. Manage. 1996, 15, 377−394.

[5] Landsbergen, D.J.; Wolken, G.J. Realizing the promise: Government information systems and the fourth generation of information technology. Public. Adm. Rev. 2001, 61, 206−220.

[6] Yang, T.M. Information-sharing in public organizations: A literature review of interpersonal, intra-organizational and inter-organizational success factors. Gov. Inform. Q. 2001, 28, 164–175.

[7] Ramon Gil-Garcia, J.; Djoko, S.S. Government inter-organizational information sharing initiatives:understanding the main determinants of success. Gov. Inform. Q. 2016, 33, 572–582

[8] Bekkers, V. Flexible information infrastructures in Dutch E-government collaboration arrangements: Experiences and policy implications. Gov. Inform. Q. 2009, 26, 60–68.

[9] Yang, T.M.; Wu, Y.J. What to share and why to share? A case study of cross-boundary information sharing in Taiwan e-government. J. Libr. Inform. Stud. 2013, 11, 25–53.

[10] Akbulut, A.Y.; Kelle, P.; Pawlowski, S.D.; Schneider, H.; Looney, C.A. To share or not to share? Examining the factors influencing local agency electronic information sharing. Int. J. Bus. Inform. Syst. 2009, 4, 143−172.

[11] Li, S.; Lin, B. Accessing information sharing and information quality in supply chain management. Decis. Support. Syst. 2006, 42, 1641−1656.

[12] Pardo, T.A.; Tayi, G.K. Interorganizational information integration: A key enabler for digital government. Gov. Inform. Q. 2007, 24, 691−715.

[13] Otjacques, B.; Hitzelberger, P.; Feltz, F. Interoperability of e-Government information systems: Issues of identification and data sharing. J. Manage. Inform. Syst. 2007, 23, 29−51.

[1]	谢程欣, 王维, 黄戈, 金鑫, 王成龙, 尹东. 中国药剂师干预减少骨科不合理用药的现状[J]. 中国药学(英文版), 2020, 29(6): 375-382.
[2]	聂玉瑶, 王贺, 周林光, 史录文, 江滨. 中国药师对仿制药认知的调查研究[J]. 中国药学(英文版), 2020, 29(5): 364-368.
[3]	聂智峰, 满春霞, 伊欣, 刘伊, 郭志刚, 管晓东, 史录文. 取消药品加成政策对57家县级公立医院医疗服务量的影响[J]. 中国药学(英文版), 2020, 29(3): 220-226.
[4]	周若婧, 江滨. 福建省药品联合限价阳光采购政策效果评估[J]. 中国药学(英文版), 2020, 29(2): 139-152.
[5]	杨东升, 马玲云, 牛剑钊, 许鸣镝. 美国授权仿制药应用简介[J]. 中国药学(英文版), 2019, 28(6): 439-445.
[6]	杨东升, 马玲云, 牛剑钊, 许鸣镝. 美国国家药品编码应用简介[J]. 中国药学(英文版), 2019, 28(3): 203-208.
[7]	尹婷, 江滨. 三明市药品限价采购政策效果研究[J]. 中国药学(英文版), 2018, 27(11): 799-804.
[8]	牛剑钊, 杨东升, 许鸣镝. 欧盟仿制药参比制剂检索与确认简介[J]. 中国药学(英文版), 2018, 27(11): 805-812.
[9]	冯书云, 郭锦辉, 卢乙众. 新医改形势下药学服务与药师价值的探索[J]. 中国药学(英文版), 2018, 27(9): 630-636.
[10]	阙梦圆, 尹婷, 李小平, 江滨. 中国基层食品药品监管资源配置现状分析[J]. 中国药学(英文版), 2018, 27(9): 637-643.
[11]	陈孝, 高翔, 陈杰, Sheryl L Chow, Moses S.S. Chow. 中国临床药学新方向: 采用“形式遵循功能”方式, 提高医疗保健效果[J]. 中国药学(英文版), 2018, 27(5): 352-360.
[12]	傅孟元, 管晓东, 魏国旭, 信枭雄, 史录文. 中国罕见病患者的医疗服务利用、经济负担和健康状况研究[J]. 中国药学(英文版), 2018, 27(5): 361-369.
[13]	林向红, 胡豪, 刘伊, 管晓东, 宋佳芳, 史录文. 中国制药企业研发国际化的影响因素综合研究[J]. 中国药学(英文版), 2018, 27(3): 209-214.
[14]	刘志艳, 聂小燕, 向倩, 史录文, 崔一民. 北京大学临床药学专业学位硕士培养模式调研反馈及Pharm. D. 培养的初步探索[J]. 中国药学(英文版), 2018, 27(2): 131-137.
[15]	张靖, 范潇予, 靳洪涛, 耿兴超. 中国药品非临床研究质量管理规范发展情况的回顾与展望[J]. 中国药学(英文版), 2017, 26(7): 534-544.

中国药品价格信息共享机制研究—基于政务信息共享理论的视角

Research on the sharing mechanism of drug price information in China- from the perspective of intergovernmental information sharing

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价